Searched for
SUN RANBAXY
Sun Pharma-Organon deal: How a $12-billion merger will reshape India's pharma landscapeSun Pharma is set to nearly double its revenue to $12 billion with the acquisition of Organon, creating a global pharmaceutical giant. The ...- Sun Pharma to acquire Organon for $11.75 billion in India’s biggest pharma dealSun Pharma, led by Dilip Shanghvi, has agreed to acquire US-based Organon in an all-cash deal worth $11.75 billion, marking the largest acq...
- Sun's strong gravity helps India Inc's pullSun Pharma has expanded its horizons by acquiring Organon, a notable New Jersey pharmaceutical firm. This strategic acquisition fortifies S...
- Sun Pharma: How a small Kolkata trader became a global buyout artistSun Pharma, led by Dilip Shanghvi, is poised for its largest overseas acquisition, a $12.5 billion deal for Organon & Co. This move continu...
- ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...
- 18 top Ranbaxy executives including Indrajit Banerjee, Yugal Sikri, get marching orders as part of integration plan with Sun PharmaThe executives have been given a severance package and the freedom to exercise their stock options before leaving.
- Ranbaxy ends last trading day on bright note; surges over 5%Sun Pharmaceutical Industries also rose by 5.51 per cent to settle at Rs 1,078.55. The stock was the top gainer among the 30-Sensex scrips.
- Sun-Ranbaxy $4 billion merger completedSun Pharmaceutical Industries today said merger of Ranbaxy with itself has been 'consummated' following receipt of requisite approvals.
- Sun-Ranbaxy $4 billion deal: US anti-trust regulator FTC passes final orderFTC has passed its final order settling charges that Sun Pharma's $4 billion deal to acquire Ranbaxy Laboratories could result in unfair bu...
- US Federal Trade Panel wraps up review of Sun Pharms's Ranbaxy acquisitionSun Pharmaceutical has moved closer to wrapping up its proposed acquisition of Ranbaxy Laboratories with the US Federal Trade Commission co...
- Sun-Ranbaxy deal gets CCI nod, with divestment riderAsked by CCI to divest seven products, drug makers Sun Pharmaceutical and Ranbaxy today said they will comply with the conditions put forth...
- Competition Commission of India may okay Sun-Ranbaxy deal with riderThe watchdog may have to set up a mechanism to ensure that the company complies with the steps it prescribed after completion of the merger.
- Sun Pharma to firm up steps to boost Ranbaxy drug salesThe drug maker also plans to draw up detailed cross-selling plans for each state, according to industry consultants familiar with the matte...
- Sun-Ranbaxy deal: CCI raises concerns about market concentration of moleculesThe CCI today said the major issue is whether the Sun-Ranbaxy deal would result in high market concentration of certain molecules.
- Sun-Ranbaxy deal, the first merger deal to get showcause notice, to be an acid test for CCISince 2011, CCI has cleared some 165 deals, including 46 in 2013 and more than 30 so far this year, according to data available on its webs...
- Daiichi files plea in Andhra Pradesh HC to vacate stay on Sun-Ranbaxy mergerThe drug maker also said that the petitioners have intermingled two separate issues - insider trading and merger process of Sun Pharma and ...
- Andhra Pradesh High Court puts on hold Sun-Ranbaxy deal till insider trade verdictShares of Ranbaxy, which is majority-owned by Japan’s Daiichi-Sankyo, saw an unusual increase in price and turnover during six trading days...
- Sun-Ranbaxy deal: How India’s biggest pharma merger is also the quickest to get done, stitched up in just 2 monthsSun and their Japanese counterparts met for the first time as recently as the third week of March. A final agreement was in place by the en...
- Sun Pharma-Ranbaxy deal: Daichi Sankyo failed to harness the complexities of a strong generic business, says Malvinder SinghThe Sun-Ranbaxy combined entity will unlock the true potential of the Gurgaon based company, says former Ranbaxy owner Malvinder Singh.
- Sun Pharma to buy Ranbaxy in $3.2 bn deal: HighlightsSun Pharmaceutical Industries said that it will buy generic drug maker Ranbaxy Laboratories, has hit regulatory snags in its key US market ...
Load More
